Volta Finance Analyst Q&A: Market conditions mean CLO vehicles can re-finance debt cheaply (LON:VTA) 21 May 2021
BBGI Global Infrastructure Analyst Q&A “shares have been robust performers over the last decade” (LON:BBGI) 19 May 2021
Serinus Energy Q&A: Q1 2021 showed the strength of cashflow generation of the business (LON:SENX) 18 May 2021
Ruffer Investment Company Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
Volta Finance Analyst Q&A: Market conditions mean CLO vehicles can re-finance debt cheaply (LON:VTA) 21 May 2021
BBGI Global Infrastructure Analyst Q&A “shares have been robust performers over the last decade” (LON:BBGI) 19 May 2021
Serinus Energy Q&A: Q1 2021 showed the strength of cashflow generation of the business (LON:SENX) 18 May 2021
Ruffer Investment Company Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
Progyny, Inc. (PGNY): Investor Outlook Reveals 11.62% Potential Upside in the Healthcare Sector 16 December 2025
Mesoblast Limited (MESO) Stock Analysis: Exploring a Potential 97.63% Upside in Regenerative Medicine 16 December 2025
Arcutis Biotherapeutics, Inc. (ARQT) Stock Report: Exploring a 9.24% Potential Upside Amid Robust Growth 16 December 2025
Enovis Corporation (ENOV) Stock Analysis: Exploring an 81% Upside Potential in the Medical Device Sector 16 December 2025
Haemonetics Corporation (HAE) Stock Analysis: 12% Upside Potential Amidst Healthcare Innovations 16 December 2025
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: A Biotech with a 44% Upside Potential 16 December 2025
NewAmsterdam Pharma (NAMS) Investor Outlook: 33.62% Upside Potential with Promising Drug Pipeline 16 December 2025
Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Unlocking a 125.92% Potential Upside 16 December 2025
Tarsus Pharmaceuticals, Inc. (TARS): Analyst Consensus and Growth Potential Point to Promising Upside 16 December 2025
IDEAYA Biosciences, Inc. (IDYA) Investor Outlook: Potential Upside of Nearly 49% Amidst Strong Buy Ratings 16 December 2025
Apellis Pharmaceuticals (APLS) Stock Analysis: Exploring a 44% Potential Upside in the Biotech Sector 16 December 2025
Kymera Therapeutics, Inc. (KYMR) Investor Outlook: Exploring a 33% Upside with Promising Buy Ratings 16 December 2025
Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A 27% Upside Potential with Strong Buy Ratings 16 December 2025
ImmunityBio, Inc. (IBRX) Investor Outlook: Examining a 368% Potential Upside with Promising Biotech Innovations 16 December 2025
MoonLake Immunotherapeutics (MLTX) Stock Report: A Biotechnology Pioneer with Promising Upside 16 December 2025
BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a Potential 171% Upside 16 December 2025
Beam Therapeutics Inc. (BEAM): Analyst Consensus Points to 71% Upside Potential for Biotech Innovator 16 December 2025
Immunovant, Inc. (IMVT) Stock Analysis: Exploring a Potential 51.79% Upside in the Biotech Sector 16 December 2025
Tate & Lyle PLC to acquire CP Kelco, strengthening expertise across three core platforms 20 June 2024
Volta Finance Analyst Q&A: Market conditions mean CLO vehicles can re-finance debt cheaply (LON:VTA) 21 May 2021
BBGI Global Infrastructure Analyst Q&A “shares have been robust performers over the last decade” (LON:BBGI) 19 May 2021
Serinus Energy Q&A: Q1 2021 showed the strength of cashflow generation of the business (LON:SENX) 18 May 2021
Ruffer Investment Company Why Defence-First Investing is Winning in Volatile Markets (Video) 22 January 2026
CQS Natural Resources Growth and Income double-digit NAV and share price gains in Dec 2025 22 January 2026
Spire Healthcare Group PLC (SPI.L) Stock Analysis: Navigating a 48.47% Potential Upside Amid Market Challenges 22 January 2026
Dr. Martens PLC (DOCS.L) Stock Analysis: Exploring the 35% Potential Upside in a Challenging Market 22 January 2026
Syncona Limited (SYNC.L) Stock Analysis: Analyst Consensus Points to Stunning 104% Upside 22 January 2026
Senior plc (SNR.L) Stock Analysis: Navigating the Aerospace & Defense Landscape with a 2.7% Upside 22 January 2026
Softcat PLC (SCT.L) Stock Analysis: A Strong ROI with 28% Potential Upside for Tech Investors 22 January 2026
